Cate Carey is a Senior Clinical Project Coordinator in the Therapeutic and Vaccine Research Programme. Cate is responsible for the coordination and implementation of large scale, multi-centre, international clinical trials. Research interests include treatment, pulmonary function and neurological affects in both HIV and infectious disease.

Senior Clinical Project Coordinator
Ms Cate Carey
RN, BA MAppSc
- Publications
Publications
Journal articles
Wyman Engen N; Huppler Hullsiek K; Belloso WH; Finley E; Hudson F; Denning E; Carey C; Pearson M; Kagan J, 2020, 'A randomized evaluation of on-site monitoring nested in a multinational randomized trial', Clinical Trials, 17, pp. 3 - 14, http://dx.doi.org/10.1177/1740774519881616
2020
Wright EJ; Grund B; Robertson KR; Cysique L; Brew BJ; Collins GL; Poehlman-Roediger M; Vjecha MJ; Penalva De Oliveira AC; Standridge B; Carey C; Avihingsanon A; Florence E; Lundgren JD; Arenas-Pinto A; Mueller NJ; Winston A; Nsubuga MS; Lal L; Price RW, 2018, 'No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell counts', AIDS, 32, pp. 985 - 997, http://dx.doi.org/10.1097/QAD.0000000000001778
2018
Lifson AR; Grund B; Gardner EM; Kaplan R; Denning E; Engen N; Carey CL; Chen F; Dao S; Florence E; Sanz J; Emery S, 2017, 'Improved quality of life with immediate versus deferred initiation of antiretroviral therapy in early asymptomatic HIV infection', AIDS, 31, pp. 953 - 963, http://dx.doi.org/10.1097/QAD.0000000000001417
2017
Larson GS; Carey C; Grarup J; Hudson F; Sachi K; Vjecha MJ; Gordin F, 2016, 'Lessons learned: Infrastructure development and financial management for large, publicly funded, international trials', Clinical Trials, 13, pp. 127 - 136, http://dx.doi.org/10.1177/1740774515625974
2016
Hullsiek KH; Kagan JM; Engen N; Grarup J; Hudson F; Denning ET; Carey C; Courtney-Rodgers D; Finley EB; Jansson PO; Pearson MT; Peavy DE; Belloso WH, 2015, 'Investigating the Efficacy of Clinical Trial Monitoring Strategies: Design and Implementation of the Cluster Randomized START Monitoring Substudy', Therapeutic Innovation and Regulatory Science, 49, pp. 225 - 233, http://dx.doi.org/10.1177/2168479014555912
2015
Grarup J; Rappoport C; Engen N; Carey C; Hudson F; Denning E; Sharma S; Florence E; Vjecha M, 2015, 'Challenges, successes and patterns of enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial', HIV Medicine, 16, pp. 14 - 23, http://dx.doi.org/10.1111/hiv.12229
2015
Lundgren J; Babiker A; Gordin F; Emery S; Fätkenheuer G; Molina JM; Wood R; Neaton JD; Agan BK; Alston-Smith B; Arenas-Pinto A; Arribas JR; Baker JV; Baxter J; Belloso WH; Brekke K; Brew B; Brobst SW; Burman W; Carey C; Clark R; Cooper DA; Davey RT; De La Rosa G; Denning ET; Dolan M; Dore G; Duprez D; Emanuel E; Grady C; Grund B; Hirschel B; Hoen B; Hudson F; Johnson MA; Kambili C; Klingman K; Kunisaki KM; Landay A; Ledergerber B; Lehrman SN; Martinez A; Meger S; Misar K; Mitsuyasu RT; Mocroft A; Munroe D; Norton M; Palmer RC; Pett SL; Phillips A; Pillay D; Porter D; Price RW; Proschan M; Rappoport C; Reiss P; Renjifo B; Robertson K; Rockstroh J; Rodriguez G; Rooney JF; Ross MJ; Schechter M; Schwarze S; Seekins D; Sharma S; Snowden W; Telenti A; Tryon J; van Wyk J; Vjecha MJ; Wright E, 2015, 'Why START? Reflections that led to the conduct of this large long-term strategic HIV trial', HIV Medicine, 16, pp. 1 - 9, http://dx.doi.org/10.1111/hiv.12227
2015
Pett SL; Carey C; Lin E; Wentworth D; Lazovski J; Miro J; Gordin F; Angus B; Rodriguez-Barradas M; Rubio R; Tambussi G; Cooper DA; Emery S, 2011, 'Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT)', HIV Medicine, 12, pp. 219 - 227, http://dx.doi.org/10.1111/j.1468-1293.2010.00875.x
2011
Tavel JA; Babiker A; Carey C; Fisher M; Fox L; Gey D; Lopardo GD; Lopez JC; Markowitz N; Munroe D; Paton N; Ruxrungtham K; Standridge B; Wentworth D; Wyman N; Aagaard B; Borup L; Grarup J; Jansson PO; Jensen K; Lundgren J; Mollerup D; Reilev S; Braimah N; Darbyshire J; Horton J; King E; Smith N; Van Hooff F; Cooper DA; Courtney-Rodgers D; Emery S; Finley E; Gordin F; Sánchez A; Thomas D; Bebchuk J; Bollenbeck P; Denning E; DuChene AG; Fosdick L; Harrison M; Krum E; Larson G; Neaton JD; Nelson R; Quan K; Quan SFL; Schultz T; Thompson G; Collins S; Haerry DH; Meulbroek M; Peavy D; Rappoport C; Schwarze S; Valdez M; Watson J; Belloso WH; Davey R; Duprez D; Gatell JM; Hoy J; Lifson A; Pederson C; Perez G; Price R; Prineas R; Rhame F; Sampson JH; Worley J; Modlin JF; Beral V; Chaisson RE; Fleming TR; Hill C; Kim KM; Murray BE; Pick B; Seligmann M; Weller I; Luzar MA; Martinez A; Costas V; Eckstrand J; Brown S; Lupo SH; Losso MH; Anderson J; Chuah J; Kelly M; Orth D; Wolff MJ; Rusconi S; Tambussi G; Horban A; Antunes F; Mansinho K; Da Conceicao Vera JAV; Himmich H, 2010, 'Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: The STALWART study', PLoS ONE, 5, http://dx.doi.org/10.1371/journal.pone.0009334
2010
Harris L; Jones M; Carey C, 2009, 'Characteristics of blood-injection-injury fears in people receiving intravenous chemotherapy', Current Psychology, 28, pp. 124 - 132, http://dx.doi.org/10.1007/s12144-009-9048-z
2009
Lifson A; Belloso WH; Carey C; Davey R; Duprez D; El-Sadr W; Gatell J; Gey D; Hoy JF; Krum E; Nelson R; Nixon D; Paton N; Pedersen C; Perez G; Price RA; Prineas R; Rhame F; Sampson J; Worley J, 2008, 'Determination of the underlying cause of death in three multicenter international HIV clinical trials', HIV Clinical Trials, 9, pp. 177 - 185, http://dx.doi.org/10.1310/hct0903-177
2008